Brain Energy Metabolism in Patients With Chronic Liver Disease and Impaired Central Nervous System
Launched by UNIVERSITY OF AARHUS · Jan 19, 2007
Trial Information
Current as of August 14, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 6 patients with liver cirrhosis with an acute episode of hepatic encephalopathy,
- • 6 patients with liver cirrhosis without an acute episode of hepatic encephalopathy,
- • 6 healthy subjects age and sex matched
- Exclusion Criteria:
- • Neurological and/or psychiatric condition,
- • Non-treated diabetes,
- • Pregnancy/breast-feeding
About University Of Aarhus
The University of Aarhus, a prestigious research institution located in Denmark, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment that encourages cutting-edge research and the development of novel therapeutic interventions. Committed to ethical standards and patient safety, the University of Aarhus aims to contribute to the global body of medical knowledge while enhancing healthcare outcomes through rigorous scientific inquiry and evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aarhus, , Denmark
Patients applied
Trial Officials
Susanne Keiding, MD
Study Chair
PET Centre and Medical department V, Aarhus Sygehus, Aarhus University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials